Director/PDMR Shareholding

Belluscura PLC

19 July 2024

 

19 July 2024

BELLUSCURA PLC

("Belluscura" or the "Company")

PDMR Award of Options

Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that the Company has today granted unapproved share options ("Options") of 4.0 million ordinary shares of 1 penny each in the Company ("Ordinary Shares") to Simon Neicheril, Chief Financial Officer. 

The Options have been awarded upon the recommendation of the Company's Remuneration Committee.

The Options have an exercise price of 14.5 pence per share (being the closing mid-market price of the Ordinary Shares on 18 July 2024) and will expire 10 years from the date of grant.

The Options are subject to the following performance criteria; 2.0 million Options will vest when the price of the Ordinary Shares reaches 20p. The further 2.0 million Options will vest when the price of the Ordinary Shares reaches 25p.  Each Option is exercisable into one Ordinary Share.

Upon a change in control of the Company, or an Offer for the Company's entire Share Capital, or termination of Mr. Neicheril's employment contract as a good leaver, all remaining unvested Options will vest immediately.

For further information please contact:

Belluscura plc	Tel: [phone]
Adam Reynolds, Chairman
Robert Rauker, Chief Executive Officer
SPARK Advisory Partners Limited - Nominated Adviser	Tel: [phone]
Neil Baldwin / Jade Bayat
Dowgate Capital Limited - Broker	Tel: [phone]
Russell Cook / Nicholas Chambers
MHP Group - Financial PR & Investor Relations	Tel: [phone]
Katie Hunt / Matthew Taylor	email: [e-mail]

About Belluscura plc (https://belluscura.com/)

Belluscura is a UK medical device company focused on developing oxygen enrichment technology spanning broad industries and therapies. Our innovative oxygen technologies are designed with a global purpose: to create improved health and economic outcomes for the patients, healthcare providers and insurance organisations.

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Simon Neicheril
2	Reason for notification
a)	Position / status	Chief Financial Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Belluscura plc
b)	LEI	213800BRJQZE56XBPW94
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of £0.01 each in Belluscura plc ISIN: GB00BD3B8Z11
b)	Nature of the transaction	Grant of Options over Ordinary shares of £0.01 each
c)	Price(s) and volumes(s)	Price(s) Volumes(s) 14.5p 4,000,000
d)	Aggregated information	n/a
e)	Date of the transaction	19 July 2024
f)	Place of the transaction	Outside a Trading Venue

 

END